Loading...
Lansen Pharmaceutical Holdings Limited
0503.HK•HKSE
Healthcare
Drug Manufacturers - Specialty & Generic
HK$1.79
HK$0.52(40.94%)
Lansen Pharmaceutical Holdings Limited (0503.HK) AI-Powered Stock Analysis
See how Lansen Pharmaceutical Holdings Limited scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full DisclaimerLansen Pharmaceutical Holdings Limited (0503.HK) Stock Overall Grade
Lansen Pharmaceutical Holdings Limited’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
B
Good
Grade Breakdown by Metric
See how each financial and market factor contributes to Lansen Pharmaceutical Holdings Limited's overall stock rating.
Forecast
C+Score
55/100Financial Growth
CScore
40/100Fundamental Growth
C+Score
50/100Key Ratios
A+Score
90/100Sector Comparison
B+Score
75/100Industry Comparison
B+Score
75/100S&P 500 Benchmark
AScore
85/100Analyst Consensus
C+Score
50/100Lansen Pharmaceutical Holdings Limited (0503.HK) AI-Powered Stock Analysis
This asset demonstrates Good performance with an overall Forecast Score of 55/100 (C+), reflecting weak confidence in its potential. Financial Growth (40/100, C) and Fundamental Growth (50/100, C+) highlight its stability, while Key Ratios (90/100, A+) and Sector Comparison (75/100, B+) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (85/100, A), it shows competitive strength. Analyst Consensus (50/100,C+) suggests High divergence in outlook.Component Analysis Explained
Understand the key factors behind each Lansen Pharmaceutical Holdings Limited stock grade, including financials, comparisons, and forecasts.